• Journal Article

Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12

Citation

Parker, J., Meleth, S., Hughes, K., Gillespie, G., Whitley, R., & Markert, J. (2005). Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12. Cancer Gene Therapy, 12(4), 359 - 368.

Abstract